Lepu Medical Technology (Beijing) Co., Ltd.
Lepu (Beijing) Medical Devices Co., Ltd. (hereinafter referred to as "Lepu Medical") was founded in 1999 and is one of the earliest enterprises in my country to engage in the research and development and manufacturing of cardiac interventional medical devices. For more than 20 years, the company has always focused on serving cardiovascular patients and drives high-quality development with innovation. It has now become the leading cardiovascular health industry platform in China. Its main business covers three major medical devices, drugs, medical services and health management. The sector was awarded the "National Research Center for the Engineering and Technology of Heart Disease Instrument and Instrument Engineering and Technology" by the Ministry of Science and Technology. The company's independently developed products such as bioabsorbable stents, cutting balloons, drug balloons, biodegradable occlusion devices, TAVR valves, artificial intelligence electrocardiocardiogram automatic analysis and diagnosis systems have reached the international leading level. In the future, Lepu Medical will continue to uphold the original intention of "serving cardiovascular patients wholeheartedly", and continue to provide full-life cycle services for disease prevention, diagnosis, drug treatment, surgical treatment, postoperative rehabilitation chronic disease management and re-prevention. On the basis of this, we will continue to increase technological innovation and actively deploy strategic emerging industries such as AI and medical care. While we are committed to providing advanced and high-quality products and services to the majority of patients, we will continue to promote industry technological progress and industrial improvement.
Lepu Medical Technology (Beijing) Co., Ltd.
Lepu (Beijing) Medical Devices Co., Ltd. (hereinafter referred to as "Lepu Medical") was founded in 1999 and is one of the earliest enterprises in my country to engage in the research and development and manufacturing of cardiac interventional medical devices. For more than 20 years, the company has always focused on serving cardiovascular patients and drives high-quality development with innovation. It has now become the leading cardiovascular health industry platform in China. Its main business covers three major medical devices, drugs, medical services and health management. The sector was awarded the "National Research Center for the Engineering and Technology of Heart Disease Instrument and Instrument Engineering and Technology" by the Ministry of Science and Technology. The company's independently developed products such as bioabsorbable stents, cutting balloons, drug balloons, biodegradable occlusion devices, TAVR valves, artificial intelligence electrocardiocardiogram automatic analysis and diagnosis systems have reached the international leading level. In the future, Lepu Medical will continue to uphold the original intention of "serving cardiovascular patients wholeheartedly", and continue to provide full-life cycle services for disease prevention, diagnosis, drug treatment, surgical treatment, postoperative rehabilitation chronic disease management and re-prevention. On the basis of this, we will continue to increase technological innovation and actively deploy strategic emerging industries such as AI and medical care. While we are committed to providing advanced and high-quality products and services to the majority of patients, we will continue to promote industry technological progress and industrial improvement.
Mindray Medical International Limited
Shenzhen Mindray Biomedical Electronics Co., Ltd. is mainly engaged in the research and development, manufacturing, marketing and services of medical devices. It is always oriented towards customer needs and is committed to providing high-quality products and services to medical institutions around the world. The company integrates innovation, closely follows clinical needs, and supports medical institutions to provide high-quality medical services, thereby helping all over the world improve medical conditions and reduce medical costs. After years of development, the company has become a global advanced medical device and solution supplier. The company is headquartered in Shenzhen, China, with 40 overseas subsidiaries in more than 30 countries in North America, Europe, Asia, Africa, Latin America and other regions; it has 17 subsidiaries and more than 40 branches in China, forming a huge number of subsidiaries. a global R&D, marketing and service network. Since its establishment, the company has been deeply engaged in the medical device field, taking the path of equal importance to endogenous and extrinsic development, constantly expanding its product lines and regions, and has experienced the expansion from a single product to multiple product lines, and from the domestic market to the global market. At present, the company's products have covered three major areas: life information and support, in vitro diagnosis and medical imaging. It has a comprehensive product line in the same industry in China, and meets clinical practice with a safe, efficient and easy-to-use "one-stop" overall solution that meets clinical practice need. The company's products and solutions have been applied to more than 190 countries and regions around the world. In the domestic market, the company's products cover nearly 110,000 medical institutions in China and more than 99% of Grade A hospitals, including the nationally renowned Peking Union Medical College Hospital, the General Hospital of the People's Liberation Army of China, and Shanghai Ruijin Hospital. In the international market, as a long-term partner of global advanced medical institutions, such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Medical Center, the company has won the United States, the United Kingdom, Germany, France, Italy. , Spain and other national medical institutions widely recognized.
Mindray Medical International Limited
Shenzhen Mindray Biomedical Electronics Co., Ltd. is mainly engaged in the research and development, manufacturing, marketing and services of medical devices. It is always oriented towards customer needs and is committed to providing high-quality products and services to medical institutions around the world. The company integrates innovation, closely follows clinical needs, and supports medical institutions to provide high-quality medical services, thereby helping all over the world improve medical conditions and reduce medical costs. After years of development, the company has become a global advanced medical device and solution supplier. The company is headquartered in Shenzhen, China, with 40 overseas subsidiaries in more than 30 countries in North America, Europe, Asia, Africa, Latin America and other regions; it has 17 subsidiaries and more than 40 branches in China, forming a huge number of subsidiaries. a global R&D, marketing and service network. Since its establishment, the company has been deeply engaged in the medical device field, taking the path of equal importance to endogenous and extrinsic development, constantly expanding its product lines and regions, and has experienced the expansion from a single product to multiple product lines, and from the domestic market to the global market. At present, the company's products have covered three major areas: life information and support, in vitro diagnosis and medical imaging. It has a comprehensive product line in the same industry in China, and meets clinical practice with a safe, efficient and easy-to-use "one-stop" overall solution that meets clinical practice need. The company's products and solutions have been applied to more than 190 countries and regions around the world. In the domestic market, the company's products cover nearly 110,000 medical institutions in China and more than 99% of Grade A hospitals, including the nationally renowned Peking Union Medical College Hospital, the General Hospital of the People's Liberation Army of China, and Shanghai Ruijin Hospital. In the international market, as a long-term partner of global advanced medical institutions, such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Medical Center, the company has won the United States, the United Kingdom, Germany, France, Italy. , Spain and other national medical institutions widely recognized.
Philips (China) Investment Co., Ltd.
Patients and medical care workers are the core of Philips' health care system. The services provided cross the boundaries of pure health care services and can provide users with a comprehensive and excellent health care service experience, which can greatly improve the patient's medical care effect and significantly reduce the Overall medical care costs. As a healthcare expert in heart disease, oncology, critical care and women, Philips is always committed to developing and providing healthcare solutions to provide users with value for money, ranging from disease prevention, radiation diagnosis to treatment, to Health management and monitoring, etc.
Philips (China) Investment Co., Ltd.
Patients and medical care workers are the core of Philips' health care system. The services provided cross the boundaries of pure health care services and can provide users with a comprehensive and excellent health care service experience, which can greatly improve the patient's medical care effect and significantly reduce the Overall medical care costs. As a healthcare expert in heart disease, oncology, critical care and women, Philips is always committed to developing and providing healthcare solutions to provide users with value for money, ranging from disease prevention, radiation diagnosis to treatment, to Health management and monitoring, etc.
Shanghai Photoelectric Medical Electronic Instrument Co., Ltd.
NIHON KOHDEN CORP. was established in 1951 and is a world-leading medical equipment research and development manufacturer. Its products cover electrocardiogram, monitoring, neuroelectrophysiology, first aid, clinical testing, laboratory equipment, and clinical information systems. and many other fields such as home health care. After more than 60 years of development, Japan Optoelectronics has grown into a global enterprise. It currently has representative institutions, R&D centers and production factories in the United States, Asia and Europe, and its sales network is spread throughout almost every country and region in the world. From 1990 to 2008, Japan Optoelectronics has successively established three branches in China: Shanghai Optoelectronics Medical Electronic Instruments Co., Ltd., Mediter Optoelectronics Medical Software (Shanghai) Co., Ltd. and Nihong Optoelectronics Trading (Shanghai) Co., Ltd. On July 1, 2012, in order to further expand the Chinese market and provide users with better products and services, Japan Optoelectronics integrated the resources of three companies and established the new Shanghai Optoelectronics Medical Electronic Instruments Co., Ltd. The new Shanghai Optoelectronics business covers five major areas: product research and development, manufacturing, market development, sales and customer service. The products not only include the traditional "NIHON KOHDEN" brand of electrocardiogram, monitoring, first aid, neuroelectrophysiology, clinical testing equipment and reagents, but also expand to the fields of electrocardiogram management systems and pharmacy equipment. New Shanghai Optoelectronics Headquarters is located in Shanghai, with more than 10 branches and offices in cities such as Beijing, Guangzhou, Shenyang, Xi'an, Nanjing, Hangzhou, Chengdu, Urumqi, Jinan and Kunming. At the same time, a 24-hour call center has been established: 400 -678-6511, provide users with more efficient and convenient support and services. Since Japan Optoelectronics entered the Chinese market in the 1960s, its excellent quality has won wide recognition from Chinese users. With the establishment of the new Shanghai Optoelectronics, it will continue to adhere to the concept of "challenging the disease with advanced electronic technology", relying on decades of deep accumulation in the field of medical equipment by Japan Optoelectronics, and provide innovative products and high-quality services to China's medical and health care. Make contributions to the development of the career.
Shanghai Photoelectric Medical Electronic Instrument Co., Ltd.
NIHON KOHDEN CORP. was established in 1951 and is a world-leading medical equipment research and development manufacturer. Its products cover electrocardiogram, monitoring, neuroelectrophysiology, first aid, clinical testing, laboratory equipment, and clinical information systems. and many other fields such as home health care. After more than 60 years of development, Japan Optoelectronics has grown into a global enterprise. It currently has representative institutions, R&D centers and production factories in the United States, Asia and Europe, and its sales network is spread throughout almost every country and region in the world. From 1990 to 2008, Japan Optoelectronics has successively established three branches in China: Shanghai Optoelectronics Medical Electronic Instruments Co., Ltd., Mediter Optoelectronics Medical Software (Shanghai) Co., Ltd. and Nihong Optoelectronics Trading (Shanghai) Co., Ltd. On July 1, 2012, in order to further expand the Chinese market and provide users with better products and services, Japan Optoelectronics integrated the resources of three companies and established the new Shanghai Optoelectronics Medical Electronic Instruments Co., Ltd. The new Shanghai Optoelectronics business covers five major areas: product research and development, manufacturing, market development, sales and customer service. The products not only include the traditional "NIHON KOHDEN" brand of electrocardiogram, monitoring, first aid, neuroelectrophysiology, clinical testing equipment and reagents, but also expand to the fields of electrocardiogram management systems and pharmacy equipment. New Shanghai Optoelectronics Headquarters is located in Shanghai, with more than 10 branches and offices in cities such as Beijing, Guangzhou, Shenyang, Xi'an, Nanjing, Hangzhou, Chengdu, Urumqi, Jinan and Kunming. At the same time, a 24-hour call center has been established: 400 -678-6511, provide users with more efficient and convenient support and services. Since Japan Optoelectronics entered the Chinese market in the 1960s, its excellent quality has won wide recognition from Chinese users. With the establishment of the new Shanghai Optoelectronics, it will continue to adhere to the concept of "challenging the disease with advanced electronic technology", relying on decades of deep accumulation in the field of medical equipment by Japan Optoelectronics, and provide innovative products and high-quality services to China's medical and health care. Make contributions to the development of the career.
Yuyue Medical Equipment Co., Ltd.
Metrax GmbH is headquartered in Rotwell (South Germany). The company is mainly engaged in the research, production and sales of medical machinery and healthcare equipment products, and has passed ISO9001, ISO13485 and CE certification from Germany TüV. The products enjoy a high reputation in the global professional market. Metrax GmbH has been developing, producing and selling high-quality emergency medical products since 1989, including PRIMEDIC™ Automatic External Defibrillator (AED) and specialized in emergency centers and hospital clinics. Defibrillator. With the launch of PRIMEDIC™ Portable Ultrasonic Devices, Manjis Co., Ltd. has expanded its product range to maintain its leading position at home and abroad.
Yuyue Medical Equipment Co., Ltd.
Metrax GmbH is headquartered in Rotwell (South Germany). The company is mainly engaged in the research, production and sales of medical machinery and healthcare equipment products, and has passed ISO9001, ISO13485 and CE certification from Germany TüV. The products enjoy a high reputation in the global professional market. Metrax GmbH has been developing, producing and selling high-quality emergency medical products since 1989, including PRIMEDIC™ Automatic External Defibrillator (AED) and specialized in emergency centers and hospital clinics. Defibrillator. With the launch of PRIMEDIC™ Portable Ultrasonic Devices, Manjis Co., Ltd. has expanded its product range to maintain its leading position at home and abroad.
Jiuxin Medical Technology (Suzhou) Co., Ltd.
Jiuxin Medical is a professional pre-hospital emergency products and solutions provider in the field of cardiovascular and development, production, sales and services. It is also a national enterprise in China that obtained the AED registration certificate for Class III medical devices. It launched China The independent brand of pre-hospital emergency product AED and its supporting IoT system management solutions. The company adheres to the mission of "caring for life and "rescuing" around you". Since its establishment, it has more than ten invention patents and has participated in the compilation of the "Technical Guidelines for the Registration of External Defibrillation Products" by the State Drug Administration. It has the technology in the field of defibrillation. Precipitation and data sample accumulation. The company has won the title of high-tech enterprise, passed the ISO quality management system certification, NMPA Class III medical device registration review and CE certification, and obtained the Class III medical device AED registration certificate. Jiuxin AED has installed nearly 40,000 units nationwide, serving the military, fire protection, public security, transportation, schools, communities, nursing homes, medical institutions, scientific research institutes, large enterprises, industrial parks, large events and other customer groups, and has Exported to Europe and Southeast Asia, it has received high praise from overseas customers. So far, Jiuxin AED has successfully saved the lives of dozens of cardiac arrest patients. In 2022, Jiuxin became an AED equipment provider for the Beijing Winter Olympics, achieving full coverage of AED for all competitions and non-competition venues in Beijing, Yanqing and Zhangjiakou, providing guarantees for the safety of all event participants. The organizing committee specially sends official thank you letter to Jiuxin for this. Jiuxin AED has now entered national venues such as the Palace Museum, the National Museum of China, and the National Library of China, actively promoting the construction of my country's urban first aid security system to help "Healthy China 2030".
Jiuxin Medical Technology (Suzhou) Co., Ltd.
Jiuxin Medical is a professional pre-hospital emergency products and solutions provider in the field of cardiovascular and development, production, sales and services. It is also a national enterprise in China that obtained the AED registration certificate for Class III medical devices. It launched China The independent brand of pre-hospital emergency product AED and its supporting IoT system management solutions. The company adheres to the mission of "caring for life and "rescuing" around you". Since its establishment, it has more than ten invention patents and has participated in the compilation of the "Technical Guidelines for the Registration of External Defibrillation Products" by the State Drug Administration. It has the technology in the field of defibrillation. Precipitation and data sample accumulation. The company has won the title of high-tech enterprise, passed the ISO quality management system certification, NMPA Class III medical device registration review and CE certification, and obtained the Class III medical device AED registration certificate. Jiuxin AED has installed nearly 40,000 units nationwide, serving the military, fire protection, public security, transportation, schools, communities, nursing homes, medical institutions, scientific research institutes, large enterprises, industrial parks, large events and other customer groups, and has Exported to Europe and Southeast Asia, it has received high praise from overseas customers. So far, Jiuxin AED has successfully saved the lives of dozens of cardiac arrest patients. In 2022, Jiuxin became an AED equipment provider for the Beijing Winter Olympics, achieving full coverage of AED for all competitions and non-competition venues in Beijing, Yanqing and Zhangjiakou, providing guarantees for the safety of all event participants. The organizing committee specially sends official thank you letter to Jiuxin for this. Jiuxin AED has now entered national venues such as the Palace Museum, the National Museum of China, and the National Library of China, actively promoting the construction of my country's urban first aid security system to help "Healthy China 2030".
Suzhou VIVS Medical Technology Co., Ltd.
Weiweisi is an innovative medical technology enterprise focusing on ventricular arrhythmia prevention and treatment and heart rhythm data services. It was founded in 2019. The company is always committed to providing the world's advanced complete solutions for the prevention, monitoring, treatment and rehabilitation of ventricular arrhythmia. In just two years, it successfully obtained the AED (automatic external defibrillator) NMPA Class III medical device registration certificate, and its products cover many countries and regions around the world, including China, Europe, Southeast Asia and other countries. The company broke the foreign monopoly and independently developed wearable automatic external defibrillator (WCD). Based on the innovation and urgency of wearable automatic external defibrillator, this product was approved by the Medical Device Technology Review Center of the State Food and Drug Administration on January 7, 2021 and entered the special review procedure for innovative medical devices, thereby enhancing my country. The ability to prevent and treat sudden cardiac death from within the hospital to outside the hospital. Weiweisi has always adhered to the corporate mission of "focusing on scientific and technological innovation and protecting heart health". In the future, we will extend the development of the world's earliest multi-parameter sudden death risk assessment system through the promotion of the wearable series of ventricular arrhythmia products and remote data service management. Through this system, Weiweisi transforms the passive treatment of sudden cardiac death into precise treatment of ventricular arrhythm management that combines prevention and treatment.
Suzhou VIVS Medical Technology Co., Ltd.
Weiweisi is an innovative medical technology enterprise focusing on ventricular arrhythmia prevention and treatment and heart rhythm data services. It was founded in 2019. The company is always committed to providing the world's advanced complete solutions for the prevention, monitoring, treatment and rehabilitation of ventricular arrhythmia. In just two years, it successfully obtained the AED (automatic external defibrillator) NMPA Class III medical device registration certificate, and its products cover many countries and regions around the world, including China, Europe, Southeast Asia and other countries. The company broke the foreign monopoly and independently developed wearable automatic external defibrillator (WCD). Based on the innovation and urgency of wearable automatic external defibrillator, this product was approved by the Medical Device Technology Review Center of the State Food and Drug Administration on January 7, 2021 and entered the special review procedure for innovative medical devices, thereby enhancing my country. The ability to prevent and treat sudden cardiac death from within the hospital to outside the hospital. Weiweisi has always adhered to the corporate mission of "focusing on scientific and technological innovation and protecting heart health". In the future, we will extend the development of the world's earliest multi-parameter sudden death risk assessment system through the promotion of the wearable series of ventricular arrhythmia products and remote data service management. Through this system, Weiweisi transforms the passive treatment of sudden cardiac death into precise treatment of ventricular arrhythm management that combines prevention and treatment.
Shenzhen Comen Medical Equipment Co., Ltd.
Shenzhen Keman Medical Equipment Co., Ltd., as a well-known medical equipment company, has products covering six major fields, including electrophysiological monitoring, electrocardiogram diagnosis, ultrasound mother-child monitoring, respiratory anesthesia, infant care and operating room equipment, with more than 50,000 Medical institutions and social service guarantee institutions enjoy Koman medical technology, products and services. Koman has three R&D departments, electrophysiology, respiratory anesthesia and baby tower, with more than 300 R&D personnel. In addition to having a headquarters production base in Shenzhen, Koman is also preparing to build a German manufacturing center. Koman company attaches importance to international talents. Strategy, with nearly 100 foreign employees. Koeman has 30 direct offices/branches in China, as well as 9 branches in the United States, Germany, Russia, India, etc. In recent years, Koeman has actively implemented and promoted the overall intellectual property strategy including patents, trademarks, copyrights, etc. As of the fourth quarter of 2017, the number of Koeman patents reached 418, PCT International patents totaled 37, and about 118 copyrights, trademark rights, etc. Koeman has obtained trademark rights in the United States, Mexico, the European Union, the African Union, India and other countries and regions. Koman developed from a small business with less than 8 people when he was founded to a well-known medical equipment supplier, relying on the spirit of hard work and struggle of the Koman people. It is the corporate culture of ideals, honors and struggle that supports Koeman's continuous development. As a world-renowned medical equipment manufacturer, adhering to the concept of end-user-centeredness, it has protected 50,000 medical institutions and social service guarantee institutions in 130 countries and regions around the world, helping to achieve the homogeneous development of medical care.
Shenzhen Comen Medical Equipment Co., Ltd.
Shenzhen Keman Medical Equipment Co., Ltd., as a well-known medical equipment company, has products covering six major fields, including electrophysiological monitoring, electrocardiogram diagnosis, ultrasound mother-child monitoring, respiratory anesthesia, infant care and operating room equipment, with more than 50,000 Medical institutions and social service guarantee institutions enjoy Koman medical technology, products and services. Koman has three R&D departments, electrophysiology, respiratory anesthesia and baby tower, with more than 300 R&D personnel. In addition to having a headquarters production base in Shenzhen, Koman is also preparing to build a German manufacturing center. Koman company attaches importance to international talents. Strategy, with nearly 100 foreign employees. Koeman has 30 direct offices/branches in China, as well as 9 branches in the United States, Germany, Russia, India, etc. In recent years, Koeman has actively implemented and promoted the overall intellectual property strategy including patents, trademarks, copyrights, etc. As of the fourth quarter of 2017, the number of Koeman patents reached 418, PCT International patents totaled 37, and about 118 copyrights, trademark rights, etc. Koeman has obtained trademark rights in the United States, Mexico, the European Union, the African Union, India and other countries and regions. Koman developed from a small business with less than 8 people when he was founded to a well-known medical equipment supplier, relying on the spirit of hard work and struggle of the Koman people. It is the corporate culture of ideals, honors and struggle that supports Koeman's continuous development. As a world-renowned medical equipment manufacturer, adhering to the concept of end-user-centeredness, it has protected 50,000 medical institutions and social service guarantee institutions in 130 countries and regions around the world, helping to achieve the homogeneous development of medical care.
Zhuo'erao Medical Technology (Shanghai) Co., Ltd.
ZOLL Medical Corporation is specialized in the research and development and production of first aid resuscitation products and solutions. ZOLL has complete defibrillation pacing technology and products, and has developed into a professional company covering first aid technologies such as automatic cardiopulmonary resuscitation, first aid cryogenic management, liquid resuscitation, first aid information system, etc. ZOLL's products and technologies help you better respond to various complex first aid needs, including pre-hospital emergency, in-hospital emergency, on-site first aid in public places, disaster rescue, and to battlefield rescue, and provide patients with timely and advanced life first aid guarantee.
Zhuo'erao Medical Technology (Shanghai) Co., Ltd.
ZOLL Medical Corporation is specialized in the research and development and production of first aid resuscitation products and solutions. ZOLL has complete defibrillation pacing technology and products, and has developed into a professional company covering first aid technologies such as automatic cardiopulmonary resuscitation, first aid cryogenic management, liquid resuscitation, first aid information system, etc. ZOLL's products and technologies help you better respond to various complex first aid needs, including pre-hospital emergency, in-hospital emergency, on-site first aid in public places, disaster rescue, and to battlefield rescue, and provide patients with timely and advanced life first aid guarantee.
Feisheng Kangche (Shanghai) Medical Devices Co., Ltd.
PhysioControl envisions a society where no one dies suddenly due to an acute, treatable medical event. The company ’s products are designed to work together to give emergency care workers greater control over critical events, no matter where they are: You work in one of the world's demanding, fast-paced environments. You need durable, powerful and connected devices to help you save lives and coordinate your team to provide higher quality care. When saving lives is the only thing that matters, the device you can rely on. Smart tools for monitoring, recording and reviewing each code event for better response next time. Cardiac arrest (SCA) has no boundaries. The company’s products and solutions can provide critical resources to help first responders — colleagues, teachers or just passers-by — save lives.
Feisheng Kangche (Shanghai) Medical Devices Co., Ltd.
PhysioControl envisions a society where no one dies suddenly due to an acute, treatable medical event. The company ’s products are designed to work together to give emergency care workers greater control over critical events, no matter where they are: You work in one of the world's demanding, fast-paced environments. You need durable, powerful and connected devices to help you save lives and coordinate your team to provide higher quality care. When saving lives is the only thing that matters, the device you can rely on. Smart tools for monitoring, recording and reviewing each code event for better response next time. Cardiac arrest (SCA) has no boundaries. The company’s products and solutions can provide critical resources to help first responders — colleagues, teachers or just passers-by — save lives.
Schiller (China) Medical Equipment Co., Ltd.
SCHILLER is an internationally leading electrocardiogram machine, dynamic electrocardiogram, dynamic blood pressure, exercise electrocardiogram and exercise cardiopulmonary, pulmonary function instrument, cardiopulmonary resuscitation, defibrillator and high-end patient monitoring (magnetic resonance hyperbaric oxygen chamber), etc. Equipment-based manufacturer. In 1974, Swiss physicist Alfred E. Schiller (President of Schiller) developed the world's smallest electrocardiogram machine Miniscope and founded SCHILLER. Dedicated to the development, production and sales of electrocardiograms and other medical diagnostic equipment. In the same year, the electrocardiogram MS-1 was produced, which immediately succeeded and led Schiller to the world market. Subsequently, Schiller continued to launch new products, gradually establishing the company's important position in the electrocardiogram field. In 2000, the company successfully acquired BRUKER, a well-known manufacturer of defibrillation products, expanding its business scope to the defibrillation field of cardiac treatment, and perfecting the entire electrocardiogram product series. In 2006, it acquired Medilog (formerly Oxford), a world-renowned dynamic ECG equipment manufacturer, further improving Schiller's product line in dynamic ECG. The company is growing in scale and currently has more than 29 branches around the world, more than 100 offices and thousands of employees. The company has a team of experienced engineers with extensive software and hardware knowledge. The ability to transform a product from the original concept to centralized production in a short period of time ensures the innovative concept of Schiller, Switzerland. And provide you with a multi-dimensional high-performance technical service.
Schiller (China) Medical Equipment Co., Ltd.
SCHILLER is an internationally leading electrocardiogram machine, dynamic electrocardiogram, dynamic blood pressure, exercise electrocardiogram and exercise cardiopulmonary, pulmonary function instrument, cardiopulmonary resuscitation, defibrillator and high-end patient monitoring (magnetic resonance hyperbaric oxygen chamber), etc. Equipment-based manufacturer. In 1974, Swiss physicist Alfred E. Schiller (President of Schiller) developed the world's smallest electrocardiogram machine Miniscope and founded SCHILLER. Dedicated to the development, production and sales of electrocardiograms and other medical diagnostic equipment. In the same year, the electrocardiogram MS-1 was produced, which immediately succeeded and led Schiller to the world market. Subsequently, Schiller continued to launch new products, gradually establishing the company's important position in the electrocardiogram field. In 2000, the company successfully acquired BRUKER, a well-known manufacturer of defibrillation products, expanding its business scope to the defibrillation field of cardiac treatment, and perfecting the entire electrocardiogram product series. In 2006, it acquired Medilog (formerly Oxford), a world-renowned dynamic ECG equipment manufacturer, further improving Schiller's product line in dynamic ECG. The company is growing in scale and currently has more than 29 branches around the world, more than 100 offices and thousands of employees. The company has a team of experienced engineers with extensive software and hardware knowledge. The ability to transform a product from the original concept to centralized production in a short period of time ensures the innovative concept of Schiller, Switzerland. And provide you with a multi-dimensional high-performance technical service.
Shenzhen Anbao Medical Technology Co., Ltd.
Shenzhen Anbao Medical Technology Co., Ltd. (hereinafter referred to as "Anbao Medical") was established in 2001. It is a national high-tech enterprise specializing in comprehensive solutions for first aid and life support. It currently has more than 700 employees. Since its establishment, it has always been committed to the research and development and industrialization of products related to critical and critical illnesses, attaches great importance to the research and development accumulation of technologies and products with independent intellectual property rights, and insists on independent innovation. It was awarded the title of Nanshan District, Shenzhen City, and Guangdong Province First Aid and Life Support Medical Equipment Engineering Technology Research Center. The company has more than 30 NMPA medical registration certificates for Class II and III medical equipment in China Food and Drug Administration, including intelligent multifunctional transport and treatment ventilators, high-flow respiratory hygrolysis therapy instruments, automatic cardiopulmonary resuscitation instruments, AED, and defibrillation monitoring More than 30 products including instruments, video laryngoscopes, electric portable suction machines, first aid training models, etc., have obtained the certification of medical devices in many regions overseas such as EU CE, US FDA, Canadian MDL. It has more than 25,000 customers in China and is exported to more than 100 countries and regions overseas. Since its inception, Security Medical has been China's general agent for first aid products for overseas enterprises. In 2004, Anbao Medical began to establish a project to independently develop emergency medical equipment, and transformed into the technology research and development and import replacement of domestic ambulance vehicles. It had obtained dual certifications of ISO9001 and ISO13485 from the German TÜV agency. In 2008, two independently developed models The first aid transfer ventilator was successfully launched and obtained the EU CE certification; in 2011, Security Medical won the national high-tech certification, and its inhalation sedation and analgesic products won the title of Shenzhen Independent Innovation Products. In 2015, Anbao Medical won the Guangdong Province and Shenzhen Excellent Patent Award; in 2018, the company won the title of "Emergency Aid and Life Support Medical Equipment Engineering Technology Research Center". In the same year, the T series intelligent transport ventilator was launched to further improve product performance. With core competitiveness; from 2020 to 2021, with the launch of a number of ventilators and cardiopulmonary resuscitation machines, the full series of CABD solutions were officially launched, and the core component research and development business unit was officially established. Security Medical takes the lead in participating in a number of projects of the Ministry of Science and Technology, provincial science and technology departments, and municipal science and technology innovation committees, completing research and development projects and achieving technical research and development. During the global outbreak of the new crown epidemic, Security Medical has successively provided various medical equipment to various parts of the world and donated more than one million epidemic prevention materials to many places across the country.
Shenzhen Anbao Medical Technology Co., Ltd.
Shenzhen Anbao Medical Technology Co., Ltd. (hereinafter referred to as "Anbao Medical") was established in 2001. It is a national high-tech enterprise specializing in comprehensive solutions for first aid and life support. It currently has more than 700 employees. Since its establishment, it has always been committed to the research and development and industrialization of products related to critical and critical illnesses, attaches great importance to the research and development accumulation of technologies and products with independent intellectual property rights, and insists on independent innovation. It was awarded the title of Nanshan District, Shenzhen City, and Guangdong Province First Aid and Life Support Medical Equipment Engineering Technology Research Center. The company has more than 30 NMPA medical registration certificates for Class II and III medical equipment in China Food and Drug Administration, including intelligent multifunctional transport and treatment ventilators, high-flow respiratory hygrolysis therapy instruments, automatic cardiopulmonary resuscitation instruments, AED, and defibrillation monitoring More than 30 products including instruments, video laryngoscopes, electric portable suction machines, first aid training models, etc., have obtained the certification of medical devices in many regions overseas such as EU CE, US FDA, Canadian MDL. It has more than 25,000 customers in China and is exported to more than 100 countries and regions overseas. Since its inception, Security Medical has been China's general agent for first aid products for overseas enterprises. In 2004, Anbao Medical began to establish a project to independently develop emergency medical equipment, and transformed into the technology research and development and import replacement of domestic ambulance vehicles. It had obtained dual certifications of ISO9001 and ISO13485 from the German TÜV agency. In 2008, two independently developed models The first aid transfer ventilator was successfully launched and obtained the EU CE certification; in 2011, Security Medical won the national high-tech certification, and its inhalation sedation and analgesic products won the title of Shenzhen Independent Innovation Products. In 2015, Anbao Medical won the Guangdong Province and Shenzhen Excellent Patent Award; in 2018, the company won the title of "Emergency Aid and Life Support Medical Equipment Engineering Technology Research Center". In the same year, the T series intelligent transport ventilator was launched to further improve product performance. With core competitiveness; from 2020 to 2021, with the launch of a number of ventilators and cardiopulmonary resuscitation machines, the full series of CABD solutions were officially launched, and the core component research and development business unit was officially established. Security Medical takes the lead in participating in a number of projects of the Ministry of Science and Technology, provincial science and technology departments, and municipal science and technology innovation committees, completing research and development projects and achieving technical research and development. During the global outbreak of the new crown epidemic, Security Medical has successively provided various medical equipment to various parts of the world and donated more than one million epidemic prevention materials to many places across the country.
Defibtech manufactures AEDs that are known for their compact design, ease of use, and affordability, making them popular in public access settings.
Defibtech, LLC
Defibtech manufactures AEDs that are known for their compact design, ease of use, and affordability, making them popular in public access settings.
HeartSine Technologies, Inc.
HeartSine produces lightweight and portable AEDs, such as the Samaritan series, which are designed for quick deployment in emergencies.
HeartSine Technologies, Inc.
HeartSine produces lightweight and portable AEDs, such as the Samaritan series, which are designed for quick deployment in emergencies.
Physio-Control is a pioneer in the development of external defibrillators, offering a range of AEDs and manual defibrillators designed for emergency medical services and hospitals.
Physio-Control, Inc.
Physio-Control is a pioneer in the development of external defibrillators, offering a range of AEDs and manual defibrillators designed for emergency medical services and hospitals.
Cardioline offers a wide range of ECG monitoring devices, known for their precision, innovative features, and reliability in clinical and ambulatory settings.
Cardioline S.p.A.
Cardioline offers a wide range of ECG monitoring devices, known for their precision, innovative features, and reliability in clinical and ambulatory settings.
Cardiac Science Corporation
Cardiac Science specializes in ECG monitoring devices, known for their advanced diagnostic capabilities, portability, and user-friendly design.
Cardiac Science Corporation
Cardiac Science specializes in ECG monitoring devices, known for their advanced diagnostic capabilities, portability, and user-friendly design.
A.M.I. Italia manufactures defibrillators, including AEDs and manual defibrillators, designed for both professional and layperson use, with a focus on reliability and ease of use.
A.M.I. Italia S.r.l.
A.M.I. Italia manufactures defibrillators, including AEDs and manual defibrillators, designed for both professional and layperson use, with a focus on reliability and ease of use.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
GE Healthcare is an innovator of global cutting-edge medical technology, diagnostic drugs and digital solutions. It is committed to making hospital operations more efficient, clinical diagnosis more effective, treatments more accurate, and patients healthier by providing integrated solutions, services, and data analysis. and happiness. In the more than 100 years of serving patients and medical institutions, GE Medical has continued to promote personalized, interconnected and more empathetic medical care, while simplifying the patient diagnosis and treatment process. GE Medical's medical imaging, ultrasound, life care and diagnostic drug business covers medical care in all aspects from diagnosis, treatment to monitoring. GE Medical was listed on the Nasdaq Stock Exchange in January 2023. The company's business covers more than 160 countries and regions. Since starting to serve Chinese patients in 1897, GE Medical has begun a century-long process of development in China. GE Medical established its China office in Beijing in 1986. In 1991, it jointly built a local factory "GE Hangwei" (Hangwei General Electric Medical Systems Co., Ltd.) with the former Ministry of Aerospace and the Ministry of Health. So far, it has been all over the country. It has more than 30 offices and has built three "creation centers" in Beijing, Wuxi and Shanghai. It has more than 7,000 employees and a local R&D team of about 1,800 people. Since 2011, it has led the research and development and marketed nearly 110 innovative products. In China, GE Medical has improved the accessibility of precision medicine and high-quality medical resources, and helped the construction of "Healthy China 2030". As one of the first multinational companies to start domestic layout, GE Medical has five major production bases (including six factories) in Beijing, Shanghai, Wuxi, Tianjin and Chengdu, and has built a "domestic" full coverage from universal and affordable to high-end. ability. GE Medical produces CT, X-ray machines, vascular machines, surgical machines and other imaging equipment in Beijing; builds a contrast agent production base in Shanghai; produces magnetic resonance imaging systems in Tianjin; produces ultrasound, anesthesia, electrocardiogram monitoring, and ventilators in Wuxi. , patient monitoring and other clinical nursing equipment. GE Medical's fifth production base in China is under construction in Chengdu; the production base of Sinopharm Devices and GE Medical Joint Venture is under construction in Shenzhen.
General Electric Company
GE Healthcare is an innovator of global cutting-edge medical technology, diagnostic drugs and digital solutions. It is committed to making hospital operations more efficient, clinical diagnosis more effective, treatments more accurate, and patients healthier by providing integrated solutions, services, and data analysis. and happiness. In the more than 100 years of serving patients and medical institutions, GE Medical has continued to promote personalized, interconnected and more empathetic medical care, while simplifying the patient diagnosis and treatment process. GE Medical's medical imaging, ultrasound, life care and diagnostic drug business covers medical care in all aspects from diagnosis, treatment to monitoring. GE Medical was listed on the Nasdaq Stock Exchange in January 2023. The company's business covers more than 160 countries and regions. Since starting to serve Chinese patients in 1897, GE Medical has begun a century-long process of development in China. GE Medical established its China office in Beijing in 1986. In 1991, it jointly built a local factory "GE Hangwei" (Hangwei General Electric Medical Systems Co., Ltd.) with the former Ministry of Aerospace and the Ministry of Health. So far, it has been all over the country. It has more than 30 offices and has built three "creation centers" in Beijing, Wuxi and Shanghai. It has more than 7,000 employees and a local R&D team of about 1,800 people. Since 2011, it has led the research and development and marketed nearly 110 innovative products. In China, GE Medical has improved the accessibility of precision medicine and high-quality medical resources, and helped the construction of "Healthy China 2030". As one of the first multinational companies to start domestic layout, GE Medical has five major production bases (including six factories) in Beijing, Shanghai, Wuxi, Tianjin and Chengdu, and has built a "domestic" full coverage from universal and affordable to high-end. ability. GE Medical produces CT, X-ray machines, vascular machines, surgical machines and other imaging equipment in Beijing; builds a contrast agent production base in Shanghai; produces magnetic resonance imaging systems in Tianjin; produces ultrasound, anesthesia, electrocardiogram monitoring, and ventilators in Wuxi. , patient monitoring and other clinical nursing equipment. GE Medical's fifth production base in China is under construction in Chengdu; the production base of Sinopharm Devices and GE Medical Joint Venture is under construction in Shenzhen.
